Buy Nebido (Testosterone undecanoate)
1000mg / 4ml Generic Nebido 100% – Analog Cernos Depot.
|Active substance||Testosterone undecanoate|
|Indian Brand||Cernos depot|
|Strength||1000mg / 4ml|
|Shipping time||7 – 21 days|
|Best price:||50.00 USD|
Testosterone undecanoate vial, sold under the brand name Nebido, Cernos Depot, is an androgen and anabolic steroid medication which is used mainly in the treatment of low testosterone levels in men. It is also used in hormone therapy for transgender men.
Order Generic Nebido, through contact page. Buy Testosterone undecanoate analog from India, we offer guarantee delivery and secure payment processing via PayPal, just contact us for prices.
Testosterone Undecanoate very popular in men, because one injection of Generic Nebido replaces any other terapies, as like capsules of testosterone ot gel. Nebido – the first registered testosterone undecanoate preparation for intramuscular injection.
Testosterone undecanoate is an ether of natural androgen, testosterone. The active form, testosterone, is formed by the cleavage of the side chain.
The half-life of nebido is long and is about 8 weeks. Each 4 ml vial contains 1000 mg of active compound (250 mg per 1 ml of solution)
Nebido injection available in a dose of 1 g of testosterone undecanoate (1 ampoule) is made 1 time in 10-14 weeks. At this frequency of injections, a sufficient level of testosterone is maintained, and the substance does not cumulate.
The drug is injected into, immediately after opening the ampoule. Inject should be made very slowly. Nebido can be entered only strictly in. Care must be taken to ensure that the drug does not get into the blood vessel.
Before starting treatment, determine the amount of testosterone in serum. The first interval between injections can be reduced, but must be at least 6 weeks. Css at this dose is achieved quickly.
At the end of the interval between injections, it is recommended to measure the serum testosterone concentration. If its level is below normal, then this fact may indicate the need to reduce the interval between injections. At high concentrations, consideration should be given to the advisability of increasing this interval. The interval between injections should remain within the recommended range of 10-14 weeks.
– androgen-dependent prostate carcinoma;
– androgen-dependent breast carcinoma in men;
– hypercalcemia associated with malignant tumors;
– liver tumors now or in history.
Submit your review